BioAegis Therapeutics

BioAegis Therapeutics, Inc. is a privately held, clinical-stage biopharmaceutical company headquartered at the NJ Bioscience Center in North Brunswick, New Jersey. Founded in 2011 around the discovery work of the late Dr. Thomas P. Stossel at Harvard Medical School and Brigham and Women's Hospital, the company develops recombinant human plasma gelsolin (rhu-pGSN) — a protein replacement therapy built on plasma gelsolin (pGSN), an abundant naturally occurring human blood protein that acts as a master regulator of the innate immune response by keeping inflammation localized to the site of injury and boosting the body's ability to clear pathogens. Its lead programme, BTI-203, is a 600-patient, 75-site, 13-country randomized double-blind placebo-controlled Phase 2 study of rhu-pGSN in moderate-to-severe acute respiratory distress syndrome (ARDS), supported by a $20M BARDA DRIVe contract (75A50123C00067); a second Phase 2 programme targets inflammasome-driven decompression sickness under a U.S. Navy Office of Naval Research contract with the University of Maryland School of Medicine. The FDA has granted Fast Track designation for both ARDS and DCS indications. BioAegis holds an exclusive worldwide license from Brigham and Women's Hospital and more than 40 issued patents spanning inflammatory disease, infection, renal failure, neurologic disease and frailty. BioAegis Therapeutics runs no developer program and publishes no product API, developer portal or API documentation. The only machine-readable surface reachable without credentials is the WordPress REST content API behind www.bioaegistherapeutics.com, catalogued here.

BioAegis Therapeutics publishes 1 API on the APIs.io network. Tagged areas include Company, Biopharmaceutical, Biotechnology, Clinical Trials, and Immunology.

The BioAegis Therapeutics catalog on APIs.io includes 1 JSON-LD context.

BioAegis Therapeutics’ developer surface includes FAQ, product news, support, YouTube channel, authentication, and 28 more developer resources.

🌐 Visit website 📡 Source on GitHub

18.9/100 emerging ▬ flat Agent 4/100 human only Front door AI 3/6 light saas Full breakdown ↓
scored 2026-09-25 · rubric v0.23.0

1 APIs

Company Biopharmaceutical Biotechnology Clinical Trials Immunology inflammationInnate ImmunitygelsolinProtein TherapeuticsardsCritical Care Rare Disease Drug Development Life Sciences content-api

Kin Score

Kin Score How this is scored →
scored 2026-09-25 · rubric v0.23.0

Composite quality — 18.9/100 · emerging

Contract Quality 1.4 / 21

Developer Ergonomics 4.8 / 17

Access Clarity 3.6 / 17

Operational Transparency 0.0 / 11

Contract Governance 0.5 / 10

Discoverability 4.9 / 9

Regulatory Posture 2.9 / 15

Agent readiness — 4/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 0 / 12

Machine-Readable Auth 10 / 10

Idempotency 0 / 9

Stable Error Semantics 8 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 5 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Delegated User Identity 0 / 6

Protected Resource Metadata 0 / 5

Registration Without a Human 0 / 6

Agentic Commerce Well-Known Document 0 / 5

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

Create-or-Update Ergonomics does not apply to this provider. The published contracts declare no write operations, and a read-only API cannot create-or-update. The facet is excluded from this provider's denominator entirely — not scored zero. A reference or data API is not deficient for being unable to upsert.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/bioaegis-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

APIs 1

Individual APIs this provider publishes, each with its own machine-readable definition.

BioAegis Therapeutics Website (WordPress REST)

The public WordPress REST API (wp-json) of the BioAegis Therapeutics website at www.bioaegistherapeutics.com: the route index of the site's content management system, catalogued...

Open Collections 1

Open, tool-agnostic API collections (OpenAPI-derived and Bruno).

API Collection

OPEN COLLECTION

Semantic Vocabularies 1

JSON-LD contexts and semantic vocabularies used across these APIs.

Bioaegis Therapeutics Organization Context

0 classes · 0 properties

JSON-LD

Security Posture 2

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Bioaegis Therapeutics Authentication

1 scheme

SECURITY

Bioaegis Therapeutics Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Get Started 1

Portal, sign-up, and the first successful call

ClinicalTrial

ClinicalTrial

Agent Surfaces 3

MCP servers, agent skills, and machine-readable catalogs

WellKnown

WellKnown

LLMsTxt

LLMsTxt

AgentSkill

AgentSkill

Design & Contract 6

Pagination, idempotency, versioning, errors, and events

Conventions

Conformance

ErrorCatalog

Lifecycle

DataModel

JSONLD

Build 1

SDKs, sample code, and the tooling you integrate with

CodeOfConduct

CodeOfConduct

Access & Security 2

Authentication, authorization, and security posture

Authentication

Authentication

DomainSecurity

DomainSecurity

Learn 1

Tutorials, courses, talks, and written guidance

YouTube

YouTube

Operate 3

Status, limits, changes, and where to get help

FAQ

FAQ

Contact

Contact

Support

Support

Commercial 2

Pricing, plans, and the legal terms of use

TermsOfService

TermsOfService

PrivacyPolicy

PrivacyPolicy

Company 7

The organization behind the API

Website

About

News

BlogRSS

Careers

LinkedIn

Twitter

Twitter

Scroll for all 7

Other 7

Properties that don't map to a standard resource type

Overlay

Science

Platform

Publications

ExpandedAccess

Sitemap

SecondaryMarket

Scroll for all 7

Source (apis.yml)

aid: bioaegis-therapeutics
name: BioAegis Therapeutics
description: BioAegis Therapeutics, Inc. is a privately held, clinical-stage biopharmaceutical company headquartered at the
  NJ Bioscience Center in North Brunswick, New Jersey. Founded in 2011 around the discovery work of the late Dr. Thomas P.
  Stossel at Harvard Medical School and Brigham and Women's Hospital, the company develops recombinant human plasma gelsolin
  (rhu-pGSN) — a protein replacement therapy built on plasma gelsolin (pGSN), an abundant naturally occurring human blood
  protein that acts as a master regulator of the innate immune response by keeping inflammation localized to the site of injury
  and boosting the body's ability to clear pathogens. Its lead programme, BTI-203, is a 600-patient, 75-site, 13-country randomized
  double-blind placebo-controlled Phase 2 study of rhu-pGSN in moderate-to-severe acute respiratory distress syndrome (ARDS),
  supported by a $20M BARDA DRIVe contract (75A50123C00067); a second Phase 2 programme targets inflammasome-driven decompression
  sickness under a U.S. Navy Office of Naval Research contract with the University of Maryland School of Medicine. The FDA
  has granted Fast Track designation for both ARDS and DCS indications. BioAegis holds an exclusive worldwide license from
  Brigham and Women's Hospital and more than 40 issued patents spanning inflammatory disease, infection, renal failure, neurologic
  disease and frailty. BioAegis Therapeutics runs no developer program and publishes no product API, developer portal or API
  documentation. The only machine-readable surface reachable without credentials is the WordPress REST content API behind
  www.bioaegistherapeutics.com, catalogued here.
deliveryModel:
  model: saas
  open_source: false
  commercial: true
  callable_host: true
  label: Hosted service · you call their endpoint
  confidence: high
  source:
  - openapi
  - pricing
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source:
  - authentication
  - security
  generated: '2026-09-03'
  method: derived
image: https://www.bioaegistherapeutics.com/wp-content/uploads/2020/08/cropped-BioAegis_Basics_white_therapeutics_scaled_with_trademark.webp
url: https://raw.githubusercontent.com/api-evangelist/bioaegis-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enriched
specificationVersion: '0.23'
created: '2026-08-07'
modified: '2026-08-07'
tags:
- Company
- Biopharmaceutical
- Biotechnology
- Clinical Trials
- Immunology
- inflammation
- Innate Immunity
- gelsolin
- Protein Therapeutics
- ards
- Critical Care
- Rare Disease
- Drug Development
- Life Sciences
- content-api
tags_raw:
- Company
- biopharmaceuticals
- biotechnology
- clinical-trials
- immunology
- inflammation
- innate-immunity
- gelsolin
- protein-therapeutics
- ards
- critical-care
- rare-disease
- drug-development
- life-sciences
- content-api
apis:
- aid: bioaegis-therapeutics:bioaegistherapeutics-com-website-wordpress-rest
  name: BioAegis Therapeutics Website (WordPress REST)
  description: 'The public WordPress REST API (wp-json) of the BioAegis Therapeutics website at www.bioaegistherapeutics.com:
    the route index of the site''s content management system, catalogued as one site surface rather than as separate APIs.'
  baseURL: https://www.bioaegistherapeutics.com/wp-json
  tags:
  - WordPress
  x-surface: platform-generated
  properties:
  - type: Documentation
    url: https://www.bioaegistherapeutics.com/wp-json
  x-platform: wordpress
  x-platform-surface: rest
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Overlay
  url: overlays/bioaegis-therapeutics-content-overlay.yaml
- type: Website
  url: https://www.bioaegistherapeutics.com/
- type: About
  url: https://www.bioaegistherapeutics.com/about-us/
- type: Science
  url: https://www.bioaegistherapeutics.com/our-science/
- type: Platform
  url: https://www.bioaegistherapeutics.com/our-platform/
- type: ClinicalTrial
  url: https://www.bioaegistherapeutics.com/bti-203-clinical-trial/
- type: Publications
  url: https://www.bioaegistherapeutics.com/publications-plasma-gelsolin/
- type: FAQ
  url: https://www.bioaegistherapeutics.com/faqs/
- type: News
  url: https://www.bioaegistherapeutics.com/news-plasma-gelsolin/
- type: BlogRSS
  url: https://www.bioaegistherapeutics.com/feed/
- type: Careers
  url: https://www.bioaegistherapeutics.com/careers/
- type: Contact
  url: https://www.bioaegistherapeutics.com/contact-us/
- type: Support
  url: https://www.bioaegistherapeutics.com/contact-us/
- type: ExpandedAccess
  url: https://www.bioaegistherapeutics.com/expanded-access-policy/
- type: CodeOfConduct
  url: https://www.bioaegistherapeutics.com/code-of-ethics-conduct/
- type: TermsOfService
  url: https://www.bioaegistherapeutics.com/terms-of-use/
- type: PrivacyPolicy
  url: https://www.bioaegistherapeutics.com/privacy-policy/
- type: LinkedIn
  url: https://www.linkedin.com/company/bioaegis-therapeutics
- type: Twitter
  url: https://twitter.com/bioaegis
- type: YouTube
  url: https://www.youtube.com/channel/UC9AflH4d_CL1TZLTBwb21HA
- type: Sitemap
  url: https://www.bioaegistherapeutics.com/sitemap_index.xml
- type: SecondaryMarket
  url: https://www.nasdaqprivatemarket.com/
- type: Authentication
  url: authentication/bioaegis-therapeutics-authentication.yml
- type: Conventions
  url: conventions/bioaegis-therapeutics-conventions.yml
- type: Conformance
  url: conformance/bioaegis-therapeutics-conformance.yml
- type: ErrorCatalog
  url: errors/bioaegis-therapeutics-problem-types.yml
- type: Lifecycle
  url: lifecycle/bioaegis-therapeutics-lifecycle.yml
- type: DataModel
  url: data-model/bioaegis-therapeutics-data-model.yml
- type: JSONLD
  url: json-ld/bioaegis-therapeutics-json-ld.yml
- type: WellKnown
  url: well-known/bioaegis-therapeutics-well-known.yml
- type: DomainSecurity
  url: security/bioaegis-therapeutics-domain-security.yml
- type: LLMsTxt
  url: llms/bioaegis-therapeutics-llms.txt
- type: AgentSkill
  url: skills/_index.yml
x-enrichment:
  date: '2026-08-07'
  status: enriched
  artifacts_added: 17
  pass: local-v1

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this

find_providersBrowse and filter every provider in the catalog.
get_provider_artifactsEvery artifact this provider publishes, grouped by type.
get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
get_provider_ratingPRO — composite, band, trend and facet scores.
apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
resolveTurn a domain, URL or GitHub org into the provider it belongs to.
find_cohortsEvery scored population of providers in the catalog.

All 92 tools →

Call it yourself

curl for this page

This provider

curl "https://apis.io/api/v1/providers/bioaegis-therapeutics"

All providers

curl "https://apis.io/api/v1/providers?limit=25"

Every operation they expose

curl "https://apis.io/api/v1/providers/bioaegis-therapeutics/operations?limit=25"

How their score was established

curl "https://apis.io/api/v1/providers/bioaegis-therapeutics/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no form to fill in. Signing in shares your email address with us — we store it to create your key and to recognise you if you sign in with another provider. See our Privacy Policy and Terms.

GitHub Google LinkedIn

A second provider on the same verified email joins the account you already have.